However, the compounded version was withdrawn from the market after pressure from the HHS and FDA
These may have side effects and varying levels of effectiveness
Retatrutide is still investigational and not approved by any regulator as of April 2026, so everything below is presented as clinical-trial data, not as medical guidance
For those that cant get Mounjaro covered, there are other options for GLP-1 medications, including semaglutide (Wegovy, Ozempic, Rybelsus), dulaglutide (Trulicity), liraglutide (Saxenda, Victoza) and other medications for weight loss
Get affordable tirzepatide (primary ingredient in Mounjaro) at an affordable price
Semaglutide has been shown to be effective for weight loss in people with obesity